Cargando…

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis

BACKGROUND: Epidemiological literature regarding the effect of polycystic ovary syndrome (PCOS) as a risk factor for non-alcoholic fatty liver disease (NAFLD) remains inconsistent. Furthermore, it remains debatable whether NAFLD is associated with PCOS as a consequence of shared risk factors or whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jia, Yao, Xin-Yu, Shi, Ru-Xia, Liu, Su-Fen, Wang, Xiao-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946415/
https://www.ncbi.nlm.nih.gov/pubmed/29747678
http://dx.doi.org/10.1186/s12978-018-0519-2
_version_ 1783322192044359680
author Wu, Jia
Yao, Xin-Yu
Shi, Ru-Xia
Liu, Su-Fen
Wang, Xiao-Yong
author_facet Wu, Jia
Yao, Xin-Yu
Shi, Ru-Xia
Liu, Su-Fen
Wang, Xiao-Yong
author_sort Wu, Jia
collection PubMed
description BACKGROUND: Epidemiological literature regarding the effect of polycystic ovary syndrome (PCOS) as a risk factor for non-alcoholic fatty liver disease (NAFLD) remains inconsistent. Furthermore, it remains debatable whether NAFLD is associated with PCOS as a consequence of shared risk factors or whether PCOS contributes to NAFLD in an independent fashion. Therefore, this meta-analysis was conducted. METHODS: This meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Relevant studies published before May 2017 were identified and retrieved from PubMed and Web of Science databases. The data were extracted, and the pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: A total of 17 studies were included into the present analysis. Compared to the control group, the risk of NAFLD in the PCOS group was higher (OR = 2.25, 95% CI = 1.95–2.60). When stratified by BMI and geographic location, the results indicated that the frequency of NAFLD risk was significantly higher in obese subjects (OR = 3.01, 95% CI = 1.88–4.82), non-obese subjects (OR = 2.07, 95% CI = 1.12–3.85), subjects from Europe (OR = 2.00, 95% CI = 1.58–2.52), subjects from the Asia-Pacific Region, (OR = 2.32, 95% CI = 1.89–2.84) and subjects from America (OR = 2.96, 95% CI = 1.93–4.55). In addition, PCOS patients with hyperandrogenism (HA) had a significantly higher risk of NAFLD, compared with controls (OR = 3.31, 95% CI = 2.58–4.24). However, there was no association between PCOS patients without HA and higher risk of NAFLD (OR = 1.46; 95% CI =0.55–3.87). The results of this meta-analysis should be interpreted with caution due to the small number of observational studies and possible confounding factors. CONCLUSION: The meta-analysis results suggest that PCOS is significantly associated with high risk of NAFLD. Although this association was independent of obesity and geographic region, it might be correlated with HA.
format Online
Article
Text
id pubmed-5946415
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59464152018-05-14 A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis Wu, Jia Yao, Xin-Yu Shi, Ru-Xia Liu, Su-Fen Wang, Xiao-Yong Reprod Health Research BACKGROUND: Epidemiological literature regarding the effect of polycystic ovary syndrome (PCOS) as a risk factor for non-alcoholic fatty liver disease (NAFLD) remains inconsistent. Furthermore, it remains debatable whether NAFLD is associated with PCOS as a consequence of shared risk factors or whether PCOS contributes to NAFLD in an independent fashion. Therefore, this meta-analysis was conducted. METHODS: This meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Relevant studies published before May 2017 were identified and retrieved from PubMed and Web of Science databases. The data were extracted, and the pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: A total of 17 studies were included into the present analysis. Compared to the control group, the risk of NAFLD in the PCOS group was higher (OR = 2.25, 95% CI = 1.95–2.60). When stratified by BMI and geographic location, the results indicated that the frequency of NAFLD risk was significantly higher in obese subjects (OR = 3.01, 95% CI = 1.88–4.82), non-obese subjects (OR = 2.07, 95% CI = 1.12–3.85), subjects from Europe (OR = 2.00, 95% CI = 1.58–2.52), subjects from the Asia-Pacific Region, (OR = 2.32, 95% CI = 1.89–2.84) and subjects from America (OR = 2.96, 95% CI = 1.93–4.55). In addition, PCOS patients with hyperandrogenism (HA) had a significantly higher risk of NAFLD, compared with controls (OR = 3.31, 95% CI = 2.58–4.24). However, there was no association between PCOS patients without HA and higher risk of NAFLD (OR = 1.46; 95% CI =0.55–3.87). The results of this meta-analysis should be interpreted with caution due to the small number of observational studies and possible confounding factors. CONCLUSION: The meta-analysis results suggest that PCOS is significantly associated with high risk of NAFLD. Although this association was independent of obesity and geographic region, it might be correlated with HA. BioMed Central 2018-05-10 /pmc/articles/PMC5946415/ /pubmed/29747678 http://dx.doi.org/10.1186/s12978-018-0519-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wu, Jia
Yao, Xin-Yu
Shi, Ru-Xia
Liu, Su-Fen
Wang, Xiao-Yong
A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title_full A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title_fullStr A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title_full_unstemmed A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title_short A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
title_sort potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946415/
https://www.ncbi.nlm.nih.gov/pubmed/29747678
http://dx.doi.org/10.1186/s12978-018-0519-2
work_keys_str_mv AT wujia apotentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT yaoxinyu apotentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT shiruxia apotentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT liusufen apotentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT wangxiaoyong apotentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT wujia potentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT yaoxinyu potentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT shiruxia potentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT liusufen potentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis
AT wangxiaoyong potentiallinkbetweenpolycysticovarysyndromeandnonalcoholicfattyliverdiseaseanupdatemetaanalysis